Cell technologies' application in practical andrology
- Authors: Glybochko P.V1, Alyaev Y.G2, Chalyi M.E2, Epifanova M.V1, Krasnov A.O2
-
Affiliations:
- Research Institute of Uronephrology and Human Reproductive Health
- Sechenov First Moscow State Medical University
- Issue: No 1S (2016): Supplement
- Pages: 44-46
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/286667
- ID: 286667
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
P. V Glybochko
Research Institute of Uronephrology and Human Reproductive Health
Email: rektorat@mma.ru
Yu. G Alyaev
Sechenov First Moscow State Medical University
Email: uro@mma.ru
Department of Urology
M. E Chalyi
Sechenov First Moscow State Medical University
Email: chaIyy@bk.ru
Department of Urology
M. V Epifanova
Research Institute of Uronephrology and Human Reproductive Health
Email: epifanova_maya@maiI.ru
A. O Krasnov
Sechenov First Moscow State Medical University
Email: krasnov_92@inbox.ru
Department of Urology
References
- Ferguson J.E. 3rd, Carson C.C. 3rd. Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons. Arab J Urol. 2013;11(3):222-229.
- Fagelman E., Fagelman A., Shabsigh R. Efficacy, safety, and use of sildenafil in urologic practice. Urology. 2001; 57: 1141-1144.
- Gonzalgo M.L., Brotzman M., Trock B.J., Geringer A.M., Burnett A.L., Jarow J.P. Clinical efficacy of sildenafil citrate and predictors of long-term response. J Urol 2003; 170: 503-506.
- Чалый М.Е., Григорян В.А., Епифанова М.В., Краснов А.О. Эффективность интракавернозного введения аутоплазмы, обогащенной тромбоцитарными факторами роста, в лечении эректильной дисфункции. Урология. 2015;4:76-79
- Albersen M., Lin C.S., Lue T. Stem-ceII therapy for erectile dysfunction. Arab J Urol. 2013;11(3):237-244.
- Чалый М.Е., Вилькин Я.Ф., Епифанова М.В. Способ лечения эректильной дисфункции. Патент на изобретение РФ № 2514639. М. 05.03.2014. Бюллетень № 12 от 27.04.2014
Supplementary files
